Michael Egholm

Person

Last mentioned: Feb 24, 2026

Timeline

Feb 24, 2026
Earnings Release

Both EVH and LAB report full-year 2025 financial results to the market.
Jan 30, 2026
Asset Realignment

Standard BioTools completes a significant acquisition/disposition of assets per SEC filings.
Jan 8, 2026
Operational Update

Standard BioTools provides preliminary 2025 performance data and strategic outlook.
Jan 5, 2024
SomaLogic Merger

Standard BioTools completes merger with SomaLogic to expand proteomics capabilities.

Stories mentioning Michael Egholm 1

Evolent and Standard BioTools Q4 Results Signal Strategic Pivot to Profitability

Evolent and Standard BioTools reported Q4 and full-year 2025 financial results, highlighting a sector-wide shift toward operational efficiency and consolidation. While Evolent scales its specialty care management platform, Standard BioTools is navigating the final stages of its SomaLogic integration amidst a complex life sciences market.

Feb 24, 2026 2 sources